LeadIQ logo
Learn more at LeadIQ.com

Insights

Key Personnel Expansion Melinta Therapeutics has recently appointed key personnel, including a Chief Technology Officer and a Vice President of Medical Affairs, indicating a focus on strengthening leadership and expertise which can present opportunities for partnership discussions with relevant stakeholders.

Product Launches & Partnerships Melinta Therapeutics has launched new products like Kimyrsa and expanded reimbursement for REZZAYO, along with forming partnerships such as the one with Venatorx Pharmaceuticals. These recent activities showcase a growing product portfolio and market presence, opening avenues for cross-promotional collaborations and sales discussions.

Sustainable Revenue Growth With a revenue range of $10M - $50M and funding of $123M, Melinta Therapeutics demonstrates stable financial health. This sustainability in revenue serves as a positive indicator for potential long-term business engagements and sales partnerships.

Innovative Therapies Melinta Therapeutics provides innovative therapies for acute and life-threatening illnesses, such as cefepime-taniborbactam and rezafungin. Leveraging their unique offerings and differentiated approach can create opportunities for targeted sales pitches and discussions within the healthcare sector.

Competitive Edge & Market Presence While similar to Par Pharmaceutical, Melinta Therapeutics sets itself apart by focusing on high touch, collaboration, and diverse teams. This unique positioning in the market can spark interest from entities seeking partnerships with a distinct brand identity and ethos, potentially leading to new sales channels and alliances.

Similar companies to Melinta Therapeutics

Melinta Therapeutics Tech Stack

Melinta Therapeutics uses 8 technology products and services including Google Analytics, SAS, Akamai, and more. Explore Melinta Therapeutics's tech stack below.

  • Google Analytics
    Analytics
  • SAS
    Business Intelligence
  • Akamai
    Content Delivery Network
  • Veeva Vault
    Enterprise Content Management
  • Twitter Emoji (Twemoji)
    Font Scripts
  • Vue.js
    Javascript Frameworks
  • Backbone.js
    Javascript Frameworks
  • Google Tag Manager
    Tag Management

Media & News

Melinta Therapeutics's Email Address Formats

Melinta Therapeutics uses at least 1 format(s):
Melinta Therapeutics Email FormatsExamplePercentage
FLast@melinta.comJDoe@melinta.com
50%
FLast@melinta.comJDoe@melinta.com
50%

Frequently Asked Questions

Where is Melinta Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Melinta Therapeutics's main headquarters is located at 389 Interpace Pkwy Suite 450 Parsippany, New Jersey 07054 US. The company has employees across 3 continents, including North AmericaEuropeAsia.

What is Melinta Therapeutics's phone number?

Minus sign iconPlus sign icon
You can contact Melinta Therapeutics's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Melinta Therapeutics's stock symbol?

Minus sign iconPlus sign icon
Melinta Therapeutics is a publicly traded company; the company's stock symbol is MLNTQ.

What is Melinta Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Melinta Therapeutics's official website is melinta.com and has social profiles on LinkedIn.

How much revenue does Melinta Therapeutics generate?

Minus sign iconPlus sign icon
As of October 2024, Melinta Therapeutics's annual revenue reached $35M.

What is Melinta Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Melinta Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Melinta Therapeutics have currently?

Minus sign iconPlus sign icon
As of October 2024, Melinta Therapeutics has approximately 154 employees across 3 continents, including North AmericaEuropeAsia. Key team members include Chief Commercial Officer: J. H.Chief Financial Officer: S. B.Chief Business Officer: J. P.. Explore Melinta Therapeutics's employee directory with LeadIQ.

What industry does Melinta Therapeutics belong to?

Minus sign iconPlus sign icon
Melinta Therapeutics operates in the Biotechnology Research industry.

What technology does Melinta Therapeutics use?

Minus sign iconPlus sign icon
Melinta Therapeutics's tech stack includes Google AnalyticsSASAkamaiVeeva VaultTwitter Emoji (Twemoji)Vue.jsBackbone.jsGoogle Tag Manager.

What is Melinta Therapeutics's email format?

Minus sign iconPlus sign icon
Melinta Therapeutics's email format typically follows the pattern of . Find more Melinta Therapeutics email formats with LeadIQ.

How much funding has Melinta Therapeutics raised to date?

Minus sign iconPlus sign icon
As of October 2024, Melinta Therapeutics has raised $123M in funding. The last funding round occurred on May 30, 2018 for $123M.
Melinta Therapeutics

Melinta Therapeutics

Biotechnology ResearchNew Jersey, United States51-200 Employees

High touch and big impact are trademarks of Melinta. We are nimble and agile without sacrificing our dedication to adding value everywhere we go.

You see, the people of Melinta are believers. Woven into the fiber of our culture is tenacity, brilliance, resilience, excellence and courage. Nothing can weaken our resolve. We take each responsibility seriously, because when we make a move, it matters.

Watch us as we grow. We are the company of the moment and the enterprise of the future. We’re unparalleled in our ability to meet the unmet needs of our patients, and we do so collaboratively. Because we believe the most diverse teams produce the most meaningful impact.

We can’t wait to make legendary strides. Every step counts.

Section iconCompany Overview

Headquarters
389 Interpace Pkwy Suite 450 Parsippany, New Jersey 07054 US
Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
MLNTQ
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
51-200

Section iconFunding & Financials

  • $123M

    Melinta Therapeutics has raised a total of $123M of funding over 14 rounds. Their latest funding round was raised on May 30, 2018 in the amount of $123M.

  • $10M$50M

    Melinta Therapeutics's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $123M

    Melinta Therapeutics has raised a total of $123M of funding over 14 rounds. Their latest funding round was raised on May 30, 2018 in the amount of $123M.

  • $10M$50M

    Melinta Therapeutics's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.